Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision tag updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded related topics: Ovarian cancer and MedlinePlus Genetics.SummaryDifference0.2%

- Check59 days agoChange DetectedRelated topic tags 'Ovarian cancer' and 'MedlinePlus Genetics' were removed from the study record's metadata. This changes how the page is categorized and surfaced in topic-based searches.SummaryDifference0.2%

- Check67 days agoChange DetectedAdded Revision: v3.4.2; removed prior notices including the lapse in government funding notice and Revision: v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.